Express News | Precipio Q4 Adj. EBITDA $400K

BenzingaFeb 25 09:30 ET

Press Release: Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (Unaudited)

Dow JonesFeb 25 09:30 ET

Express News | Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted Ebitda and Positive Cash Flow (Unaudited)

ReutersFeb 25 09:30 ET

Precipio, Inc. (NASDAQ:PRPO) Soars 26% But It's A Story Of Risk Vs Reward

Simply Wall StJan 22 05:17 ET

Precipio, Inc. Introduces Performance-Based Vesting for Senior Management Stock Options to Drive Company Growth

Quiver QuantitativeJan 16 17:10 ET

Precipio Grants Senior Management Performance-based Awards Instead of Traditional Time-vested ESOPs

GlobeNewswireJan 16 17:00 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaJan 16 07:05 ET

Insider Sale: Director at $PRPO (PRPO) Sells 12,000 Shares

Quiver QuantitativeDec 13, 2024 16:48 ET

Precipio Reports Improved Financials Amid Challenges

TipRanksNov 18, 2024 23:01 ET

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 18, 2024 18:25 ET · Conference Call

Here Are the Major Earnings After the Close Today

Seeking AlphaNov 18, 2024 10:00 ET

Precipio (PRPO.US) will release its financial report after market close on November 18th.

$Precipio(PRPO.US)$ will release its financial report after the market closes on November 18, investors are requested to pay attention. How has the performance been before? $Precipio(PRPO.US)$'s revenue for 2024/Q2 was $4.441 million, net income was -$-1.22 million, and EPS was -$0.83. The revenue for 2023/Q3 was $4.518 million, net income was -$-1.455 million, and EPS was -$1.04. The above data is based on US_GAAP accounting standards. Futubull reminder: 1. The financial year for companies listed on the Hong Kong and US stock exchanges

Moomoo NewsNov 12, 2024 20:00 ET

Precipio Third Quarter 2024 Earnings: US$0.42 Loss per Share (Vs US$1.04 Loss in 3Q 2023)

Yahoo FinanceNov 9, 2024 09:10 ET

Precipio Announces Q3-2024 Shareholder Update Call

GlobeNewswireNov 6, 2024 17:00 ET

Precipio | 10-Q: Q3 2024 Earnings Report

SECNov 6, 2024 16:08 ET · Announcements

Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping

GlobeNewswireOct 8, 2024 10:00 ET

GenomOncology Partners With Precipio to Advance Myeloid Testing and Reporting

PR NewswireSep 10, 2024 08:30 ET

Express News | Precipio Inc - Options Granted in 2023 and in 2024 Will Remain Unaltered

ReutersSep 6, 2024 16:03 ET

Express News | Precipio- Repricing Stock Options Granted Prior to Year-End 2022, Representing About 58% of Total Outstanding Options

ReutersSep 6, 2024 16:02 ET

Precipio Announces Employee Stock Option Plan Repricing

GlobeNewswireSep 6, 2024 16:00 ET